期刊文献+

硝酸甘油治疗心衰中输液泵的应用价值 被引量:2

Value of infusion pump in treatment of heart failure with nitroglycerin
下载PDF
导出
摘要 目的探讨在使用硝酸甘油治疗心衰过程中两种方法的效果。方法将62例患者随机分组至一般输液组和输液泵组。对不良反应出现率、调节滴速消耗的时间、输液中需要调节滴速次数进行比较。结果一般输液组滴速调节平均时间为(87.2±11.5)s/次,输液泵组为(6.8±1.3)s/次。两组时间上差别有统计学意义(P<0.01)。输液泵组需要调节速度的次数明显比一般输液组少,输液泵组无一过性低血压现象发生,仅发生2例不良反应。结论输液泵输液法和一般输液法相比,节省护士精力、体力,提高了病人输液的安全性。 Objective To investigate the effects of two methods in the treatment of heart failure with nitroglycerin. Methods A total of 62 patients were randomly divided into conventional infusion group and infusion pump group. The two groups were compared in terms of the incidence rate of adverse events, time spent adjusting the infusion speed, and number of necessary adjustments of the infusion speed. Results There was a significant difference in the mean time spent adjusting the infusion speed between the conventional infusion group and the infusion pump group(87.2 ±11.5 s/time vs 6.8 ±1.3 s/time, P〈0.01). The infusion pump group had a significantly lower number of necessary adjustments of the infusion speed than the conventional infusion group. No patient in the infusion pump group experienced transient hypotension, and there were only 2 cases of adverse events. Conclusion Compared with conventional infusion, infusion pump saves the energy of nurses and improves of the safety of infusion.
作者 王常畅
出处 《心血管病防治知识(学术版)》 2018年第1期60-61,共2页 Prevention and Treatment of Cardiovascular Disease
关键词 输液泵 硝酸甘油 心衰 Infusion pump Nitroglycerin Heart failure
  • 相关文献

参考文献3

二级参考文献90

  • 1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 2无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2090
  • 3中华医学会心血管病学分会 中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用的专家共识[J].中华心血管病杂志,2009,37:195-209.
  • 4中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
  • 5Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416.
  • 6Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442.
  • 7Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure ). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart fa/lure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005, 46: e1-e82.
  • 8Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Aduks: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 2009, 119: 1977-2016.
  • 9Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med, 2008, 36(1 Suppl) : S75-S88.
  • 10Chen D, Assad-Kottner C, Orrego C, et al. Cytokines and acute heart failure. Crit Care Med, 2008, 36(1 Suppl) : S9-S16.

共引文献886

同被引文献7

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部